Skip to main content

Assessment of mid flow rate measurements in patients undergoing methacholine challenge

Buy Article:

$39.50 plus tax (Refund Policy)

Abstract:

The objective of this study is to assess the FEF25–75 and FEF25–75/FVC in relation to the FEV1 in patients who have had a methacholine inhalation challenge study for a variety of clinical indications. The study is a retrospective review of methacholine challenge results at the university medical center. One hundred twenty-one consecutive patients who had a methacholine challenge performed for clinical indications were included in the study with no intervention. Methacholine was administered in successively increasing twofold concentrations in doses from 0.62 mg to a final concentration of 10 mg. A 20% drop in FEV1compared to the prechallenge value was considered a positive test. We considered ≥25% decrease in FEF25–75 as a significant change. The ≥25% decrease in FEF25–75 occurred sooner than the 20% drop in FEV1 with a positive response occurring at least one full dose sooner in 23 of the 55 subjects. Thirty two subjects reacted at the same dose. The dose at which the FEF25–75 decreased by ≥25% was significantly different from the corresponding dose causing a 20% decrease in FEV1. The FEF25–75 decreases more per mg methacholine. There were no subjects in whom there was ≥20% decrease in FEV1 without a ≥25% decrease in FEF25–75. The mean FEF25–75/FVC after diluent inhalation = 0.87 ± 0.27 standard deviation with a range of 0.23 to 1.67. The doses at which the FEF25–75/FVC decreased by ≥20% and by ≥30% was significantly lower than the corresponding doses causing a 20% decrease in FEV1. FEF25–75 and the FEF25–75/FVC are more sensitive but less specific than the FEV1 as indicators of a positive response to a methacholine challenge. The FEF25–75/FVC does not provide additional information to that provided by the FEF25–75.

Document Type: Research Article

DOI: https://doi.org/10.2500/aap.2006.27.2903

Publication date: 2006-07-01

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • www.AJRA.com
  • www.AllergyandRhinology.com
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more